Myda Advisors LLC Kezar Life Sciences, Inc. Transaction History

Myda Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$2.77 - $5.75 $76,188 - $158,153	-27,505 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.5 - $4.26 $68,762 - $117,171	27,505 New	27,505 $110,000
Q3 2018 Nov 14, 2018	SELL	$15.5 - $21.41 $190,665 - $263,364	-12,301 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$17.15 - $17.79 $210,962 - $218,834	12,301 New	12,301 $213,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $521M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.